James Matthaei
About James Matthaei
James Matthaei is a Senior Scientist II at Sonoma Biotherapeutics in Seattle, Washington, where he has worked since 2022. He has a strong background in protein engineering and cell therapies, with extensive experience in both academic and industry settings.
Work at Sonoma BioTherapeutics
James Matthaei has been employed at Sonoma Biotherapeutics since 2020, progressing through various roles. He started as a Scientist from 2020 to 2021, then served as a Senior Scientist for 10 months in 2021. Currently, he holds the position of Senior Scientist II, a role he has maintained since 2022. His work focuses on protein engineering and cell therapies, where he leads multiple projects and demonstrates a strong ability to execute experiments effectively.
Education and Expertise
James Matthaei earned his Doctor of Philosophy (Ph.D.) in Chemical Engineering from the University of Washington, where he studied from 2007 to 2015. He also obtained a Master's Degree in the same field from the same institution, completing his studies from 2007 to 2009. His undergraduate education was at Whitman College, where he achieved a Bachelor's Degree in Mathematics and Rhetoric & Film from 2001 to 2006. His educational background supports his expertise in protein engineering and cell therapies.
Background
Before his tenure at Sonoma Biotherapeutics, James Matthaei worked in various roles that contributed to his scientific career. He was a Postdoctoral Fellow at Seattle Children's from 2015 to 2020. Prior to that, he served as a Doctoral Researcher at the University of Washington for eight years, from 2007 to 2015. He also worked as a Rock Climbing Instructor and Trip Leader at Whitman College from 2002 to 2006, where he developed leadership and instructional skills.
Achievements
James Matthaei is recognized for his collaborative approach and purpose-driven mindset in scientific research. He has demonstrated a proven ability to conceptualize and execute experiments effectively, leading multiple projects in fast-paced environments. His strong foundation in protein engineering and cell therapies has positioned him as a valuable contributor to the field.